|
Drug Therapy, Other
Citations 171-180 of 211 total displayed.
|
Past content
(since Nov 1998):
|
- The Cutting Edge
Successful Use of Rituximab for Cutaneous Vasculitis
- Lorinda Chung; Alisa A. Funke; Eliza F. Chakravarty; Jeffrey P. Callen; David F. Fiorentino
Arch Dermatol 2006; 142: 1407-1410.
[Extract]
[Full text]
[PDF]
- Studies
A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus
- Stefan Beissert; Thomas Werfel; Uta Frieling; Markus Böhm; Michael Sticherling; Rudolf Stadler; Detlev Zillikens; Berthold Rzany; Nicolas Hunzelmann; Michael Meurer; Harald Gollnick; Thomas Ruzicka; Hans Pillekamp; Volker Junghans; Thomas A. Luger
Arch Dermatol 2006; 142: 1447-1454.
[Abstract]
[Full text]
[PDF]
- Observations
Successful Treatment of Mucous Membrane Pemphigoid With Etanercept in 3 Patients
- Maria J. Canizares; David I. Smith; Michael S. Conners; Kenneth J. Maverick; Michael P. Heffernan
Arch Dermatol 2006; 142: 1457-1461.
[Abstract]
[Full text]
[PDF]
- Observations
Livedoid Vasculopathy Associated With Plasminogen Activator Inhibitor-1 Promoter Homozygosity (4G/4G) Treated Successfully With Tissue Plasminogen Activator
- April Deng; Christopher D. Gocke; John Hess; Meyer Heyman; Michael Paltiel; Anthony Gaspari
Arch Dermatol 2006; 142: 1466-1469.
[Abstract]
[Full text]
[PDF]
- Editorials
Livedoid Vasculopathy: What It Is and How the Patient Should Be Evaluated and Treated
- Jeffrey P. Callen
Arch Dermatol 2006; 142: 1481-1482.
[Extract]
[Full text]
[PDF]
- Correspondence
Transdermal Therapy for Erythromelalgia
- Jay S. Cohen
Arch Dermatol 2006; 142: 1508-a.
[Extract]
[Full text]
[PDF]
- Correspondence
Long-term Control of Papular Dermatitis ("Dermal Hypersensitivity Reaction") With Mycophenolate Mofetil
- Scott L. Flugman
Arch Dermatol 2006; 142: 1512-1513.
[Extract]
[Full text]
[PDF]
- The Cutting Edge
Severe Hidradenitis Suppurativa Treated With Adalimumab
- Danielle K. Moul; Neil J. Korman
Arch Dermatol 2006; 142: 1110-1112.
[Extract]
[Full text]
[PDF]
- Studies
1% Pimecrolimus, 0.005% Calcipotriol, and 0.1% Betamethasone in the Treatment of Intertriginous Psoriasis: A Double-blind, Randomized Controlled Study
- Alexander Kreuter; Anna Sommer; Julia Hyun; Matthias Bräutigam; Norbert H. Brockmeyer; Peter Altmeyer; Thilo Gambichler
Arch Dermatol 2006; 142: 1138-1143.
[Abstract]
[Full text]
[PDF]
- Evidence-Based Dermatology: Research Commentaries
Two "Positive" Studies of Probiotics for Atopic Dermatitis: Or Are They?
- Hywel C. Williams
Arch Dermatol 2006; 142: 1201-1203.
[Extract]
[Full text]
[PDF]
|
|
